• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠球菌固有和获得性耐药机制。

Intrinsic and acquired resistance mechanisms in enterococcus.

机构信息

Department of Medicine, Lifespan/Rhode Island Hospital and Alpert Medical School of Brown University, Providence, RI, USA.

出版信息

Virulence. 2012 Aug 15;3(5):421-33. doi: 10.4161/viru.21282.

DOI:10.4161/viru.21282
PMID:23076243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3485979/
Abstract

Enterococci have the potential for resistance to virtually all clinically useful antibiotics. Their emergence as important nosocomial pathogens has coincided with increased expression of antimicrobial resistance by members of the genus. The mechanisms underlying antibiotic resistance in enterococci may be intrinsic to the species or acquired through mutation of intrinsic genes or horizontal exchange of genetic material encoding resistance determinants. This paper reviews the antibiotic resistance mechanisms in Enterococcus faecium and Enterococcus faecalis and discusses treatment options.

摘要

肠球菌具有几乎对所有临床有用的抗生素的耐药潜力。随着该属成员对抗微生物药物耐药性表达的增加,它们作为重要的医院获得性病原体出现。肠球菌中抗生素耐药性的机制可能是物种固有的,也可能是通过内在基因的突变或编码耐药决定因素的遗传物质的水平交换获得的。本文综述了屎肠球菌和粪肠球菌的抗生素耐药机制,并讨论了治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d05/3485979/282d56337be3/viru-3-421-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d05/3485979/282d56337be3/viru-3-421-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d05/3485979/282d56337be3/viru-3-421-g1.jpg

相似文献

1
Intrinsic and acquired resistance mechanisms in enterococcus.肠球菌固有和获得性耐药机制。
Virulence. 2012 Aug 15;3(5):421-33. doi: 10.4161/viru.21282.
2
Occurrence of Enterococcus faecalis and Enterococcus faecium in Various Clinical Infections: Detection of Their Drug Resistance and Virulence Determinants.粪肠球菌和屎肠球菌在各种临床感染中的发生情况:检测它们的耐药性和毒力决定因素。
Microb Drug Resist. 2018 Jan/Feb;24(1):76-82. doi: 10.1089/mdr.2017.0049. Epub 2017 May 19.
3
Emergence of High-level Gentamicin Resistance among Clinical Isolates from Burn Patients in South-west of Iran: Vancomycin Still Working.伊朗西南部烧伤患者临床分离株中高水平庆大霉素耐药性的出现:万古霉素仍然有效。
Pol J Microbiol. 2018;67(4):401-406. doi: 10.21307/pjm-2018-043.
4
The emerging problem of linezolid-resistant enterococci.耐(linezolid)利(novel)糖(tetracycline)肠球菌的新兴问题。
J Glob Antimicrob Resist. 2018 Jun;13:11-19. doi: 10.1016/j.jgar.2017.10.018. Epub 2017 Oct 31.
5
Antibiotic resistant enterococci-tales of a drug resistance gene trafficker.耐抗生素肠球菌——耐药基因传播者的故事。
Int J Med Microbiol. 2013 Aug;303(6-7):360-79. doi: 10.1016/j.ijmm.2013.03.001. Epub 2013 Mar 8.
6
Antibiotic resistance and virulence traits in clinical and environmental Enterococcus faecalis and Enterococcus faecium isolates.临床和环境粪肠球菌和屎肠球菌分离株的抗生素耐药性和毒力特征。
Syst Appl Microbiol. 2012 Jul;35(5):326-33. doi: 10.1016/j.syapm.2012.05.004. Epub 2012 Jun 26.
7
Glycopeptide-resistant enterococci: deciphering virulence, resistance and epidemicity.耐糖肽肠球菌:解读其毒力、耐药性及流行性
Curr Opin Infect Dis. 2007 Aug;20(4):384-90. doi: 10.1097/QCO.0b013e32818be63d.
8
Antibiotic heteroresistance and persistence: an additional aid in hospital acquired infections by spp.?抗生素异质性耐药和持久性:是否有助于 spp. 引起的医院获得性感染?
Future Microbiol. 2024;19(16):1407-1418. doi: 10.1080/17460913.2024.2393003. Epub 2024 Sep 4.
9
Phenotypic and genotypic study of biofilm formation in Enterococci isolated from urinary tract infections.从尿路感染中分离出的肠球菌生物膜形成的表型和基因型研究。
Microb Pathog. 2017 Jul;108:85-90. doi: 10.1016/j.micpath.2017.05.014. Epub 2017 May 5.
10
Antimicrobial susceptibilities of enterococci isolated from hospitalized patients.从住院患者中分离出的肠球菌的抗菌药敏性。
Antimicrob Agents Chemother. 1993 May;37(5):1190-2. doi: 10.1128/AAC.37.5.1190.

引用本文的文献

1
Fluorescent Peptides Internalize HeLa Cells and Kill Multidrug-Resistant Clinical Bacterial Isolates.荧光肽可内化进入HeLa细胞并杀死多重耐药临床细菌分离株。
Antibiotics (Basel). 2025 Aug 4;14(8):793. doi: 10.3390/antibiotics14080793.
2
Investigation of mobile genetic elements and their association with antibiotic resistance genes in clinical pathogens worldwide.全球临床病原体中移动遗传元件及其与抗生素抗性基因的关联研究。
PLoS One. 2025 Aug 18;20(8):e0330304. doi: 10.1371/journal.pone.0330304. eCollection 2025.
3
mutants have cell envelope defects influencing antibiotic resistance and bacteriophage susceptibility.

本文引用的文献

1
Trends in susceptibility of vancomycin-resistant Enterococcus faecium to tigecycline, daptomycin, and linezolid and molecular epidemiology of the isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006 to 2010.万古霉素耐药屎肠球菌对替加环素、达托霉素和利奈唑胺敏感性的趋势及分离株的分子流行病学:来自 2006 年至 2010 年台湾替加环素体外监测(TIST)研究的结果。
Antimicrob Agents Chemother. 2012 Jun;56(6):3402-5. doi: 10.1128/AAC.00533-12. Epub 2012 Apr 9.
2
Tigecycline-resistant Enterococcus faecalis associated with omeprazole use in a surgical patient.一名外科患者中与使用奥美拉唑相关的耐替加环素粪肠球菌。
J Antimicrob Chemother. 2012 Jul;67(7):1806-7. doi: 10.1093/jac/dks122. Epub 2012 Mar 27.
3
突变体具有影响抗生素抗性和噬菌体敏感性的细胞包膜缺陷。
bioRxiv. 2025 Jul 21:2025.07.21.665895. doi: 10.1101/2025.07.21.665895.
4
Genomic and clinical characterization of linezolid resistance in Enterococcus species from cancer patients in China.中国癌症患者肠球菌属中利奈唑胺耐药性的基因组和临床特征
BMC Infect Dis. 2025 Aug 7;25(1):989. doi: 10.1186/s12879-025-11371-x.
5
CAUTIon - not all UTIs are the same.注意——并非所有尿路感染都是相同的。
Nat Rev Urol. 2025 Aug 1. doi: 10.1038/s41585-025-01065-z.
6
Characterization of associated with root canal failures: Virulence and resistance profile.与根管治疗失败相关的特征:毒力和耐药性概况。
J Conserv Dent Endod. 2025 Jul;28(7):602-606. doi: 10.4103/JCDE.JCDE_190_25. Epub 2025 Jul 2.
7
Phosphorylation of the cell wall hydrolase MltG in response to cell wall stress modulates resistance toward cephalosporins in .细胞壁水解酶MltG在响应细胞壁应激时的磷酸化调节了对头孢菌素的抗性。
J Bacteriol. 2025 Jul 14:e0009925. doi: 10.1128/jb.00099-25.
8
Unveiling the probiotic potential of Enterococcus spp.: Mechanisms and roles in animal and human health, A comprehensive review.揭示肠球菌属的益生菌潜力:动物和人类健康中的机制与作用,全面综述
World J Microbiol Biotechnol. 2025 Jun 25;41(7):214. doi: 10.1007/s11274-025-04389-5.
9
The cell wall hydrolase MltG is essential to maintain cell wall homeostasis of .细胞壁水解酶MltG对于维持……的细胞壁稳态至关重要。 (原文中“of”后面缺少具体内容)
J Bacteriol. 2025 Jul 24;207(7):e0005625. doi: 10.1128/jb.00056-25. Epub 2025 Jun 13.
10
Assessment of Factors Contributing to Infection Severity and High Levels of Drug Resistance in Clinical Enterococcus Isolates.临床分离肠球菌感染严重程度及高耐药性相关因素评估
J Clin Lab Anal. 2025 Jul;39(14):e70063. doi: 10.1002/jcla.70063. Epub 2025 May 27.
Genomic and SNP analyses demonstrate a distant separation of the hospital and community-associated clades of Enterococcus faecium.
基因组和 SNP 分析表明,粪肠球菌医院和社区相关分支簇在遥远的地方分离。
PLoS One. 2012;7(1):e30187. doi: 10.1371/journal.pone.0030187. Epub 2012 Jan 26.
4
First report of the multidrug resistance gene cfr in Enterococcus faecalis of animal origin.首次报道动物源屎肠球菌携带耐多药基因 cfr。
Antimicrob Agents Chemother. 2012 Mar;56(3):1650-4. doi: 10.1128/AAC.06091-11. Epub 2011 Dec 27.
5
In vitro activity effects of twelve antibiotics alone and in association against twenty-seven Enterococcus faecalis strains isolated from Italian patients with infective endocarditis: high in vitro synergistic effect of the association ceftriaxone-fosfomycin.体外研究 12 种抗生素单独及联合应用对 27 株源自意大利感染性心内膜炎患者粪肠球菌的活性作用:头孢曲松-磷霉素联合具有高度体外协同作用。
Chemotherapy. 2011;57(5):426-33. doi: 10.1159/000330458. Epub 2011 Nov 26.
6
vanA-containing Enterococcus faecium susceptible to vancomycin and teicoplanin because of major nucleotide deletions in Tn1546.对万古霉素和替考拉宁敏感的含 vanA 肠球菌,是由于 Tn1546 中的主要核苷酸缺失。
J Antimicrob Chemother. 2011 Dec;66(12):2758-62. doi: 10.1093/jac/dkr379. Epub 2011 Sep 15.
7
Genetic basis for in vivo daptomycin resistance in enterococci.肠球菌体内达托霉素耐药的遗传基础。
N Engl J Med. 2011 Sep 8;365(10):892-900. doi: 10.1056/NEJMoa1011138.
8
D-Ala-d-Ser VanN-type transferable vancomycin resistance in Enterococcus faecium.屎肠球菌中 D-Ala-d-Ser 型 VanN 型转移型万古霉素耐药性。
Antimicrob Agents Chemother. 2011 Oct;55(10):4606-12. doi: 10.1128/AAC.00714-11. Epub 2011 Aug 1.
9
Gentamicin improves the activities of daptomycin and vancomycin against Enterococcus faecalis in vitro and in an experimental foreign-body infection model.庆大霉素可提高达托霉素和万古霉素对粪肠球菌的体外和实验性异物感染模型的活性。
Antimicrob Agents Chemother. 2011 Oct;55(10):4821-7. doi: 10.1128/AAC.00141-11. Epub 2011 Aug 1.
10
LEADER Program results for 2009: an activity and spectrum analysis of linezolid using 6,414 clinical isolates from 56 medical centers in the United States.利奈唑胺 2009 年 LEADER 项目研究结果:来自美国 56 家医疗中心的 6414 株临床分离菌的活性和谱分析。
Antimicrob Agents Chemother. 2011 Aug;55(8):3684-90. doi: 10.1128/AAC.01729-10. Epub 2011 Jun 13.